Figure 2.
OS with Pola-R-CHP and R-CHOP in older patients. (A) Aged ≥60 years, (B) ≥65 years, (C) ≥70 years, and (D) ≥75 years from the POLARIX study (efficacy-evaluable population). Unstratified log-rank analysis.
OS with Pola-R-CHP and R-CHOP in older patients. (A) Aged ≥60 years, (B) ≥65 years, (C) ≥70 years, and (D) ≥75 years from the POLARIX study (efficacy-evaluable population). Unstratified log-rank analysis.
